Nova Tina Susan
- SEC CIK
- 0001302605
No open-market purchases or sales filed in the past year.
Current role at each company
- AUPH Aurinia Pharmaceuticals Inc.Directoras of Jun 8, 2026
- AZTA Azenta, Inc.Directoras of Feb 6, 2026
- XGN Exagen Inc.Directoras of Jun 12, 2025
- ARNA Arena Pharmaceuticals IncDirectoras of Mar 11, 2022
- VCYT Veracyte, Inc.President, CLIA U.S.as of Mar 7, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Nova Tina Susan as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
No insider trades match these filters.